Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

Ruben Gonzalez is presenting “Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles” at the 2022 Drug & Medical Device Litigation Conference in New York City. The panel discussion will include:

• Looking Beyond Albrecht: Analyzing the potential implications of Dobbs v. Jackson Women’s Health Organization on future preemption battles involving state attempts to ban FDA-approved drugs
• Could the Court’s recent decision limiting the authority of the EPA potentially impact the FDA’s future ability to enforce their regulations in the drug and device space?
• Views from Supreme Court practitioners on how the current division in the Court is impacting their approach to argument and their decisions on appellate issues